Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Disseminated Xanthogranuloma Harboring a GAB2::BRAF Fusion and MITF Pathogenic Variant Successfully Treated With Cobimetinib: A Rare Case Report. Local targets link to admitted publications; unresolved targets remain external evidence.
Cutaneous Disseminated Xanthogranuloma in an Adult: Case Report and Review of the Literature
2009 · External reference
Congenital Xanthoma Multipex in a Child
1905 · External reference
10.1111/j.1365-2133.1912.tb16720.x
10.1111/j.1365-2133.1912.tb16720.x · External reference
Juvenile Xanthogranuloma (Nevoxanthoendothelioma)
1954 · External reference
Nevoxanthoendothelioma With Small and Large Nodules. Report on 13 Cases
1963 · External reference
10.1097/00000478-200305000-00003
10.1097/00000478-200305000-00003 · External reference
10.1182/asheducation-2015.1.571
10.1182/asheducation-2015.1.571 · External reference
10.1038/modpathol.2017.50
10.1038/modpathol.2017.50 · External reference
10.1038/s41591-019-0653-6
10.1038/s41591-019-0653-6 · External reference
10.1016/s1470-2045(17)30031-1
10.1016/s1470-2045(17)30031-1 · External reference
10.1002/pbc.24772
10.1002/pbc.24772 · External reference
10.1038/s41572-021-00307-9
10.1038/s41572-021-00307-9 · External reference
Dasatinib Induces a Dramatic Response in a Child With Refractory Juvenile Xanthogranuloma With a Novel MRC1‐PDGFRB Fusion
10.1182/bloodadvances.2020001890 · 2020 · External reference
BRAF V600E Mutation in Juvenile Xanthogranuloma Family Neoplasms of the Central Nervous System (CNS‐JXG): A Revised Diagnostic Algorithm to Include Pediatric Erdheim‐Chester Disease
10.1186/s40478-019-0811-6 · 2019 · External reference
Disseminated Juvenile Xanthogranuloma Harbouring a GAB2::BRAF Fusion Successfully Treated With Trametinib: A Case Report
10.1093/bjd/ljae328 · 2025 · External reference
A Novel GAB2::BRAF Fusion in Cutaneous Non‐Langerhans‐Cell Histiocytosis With Systemic Involvement
10.1111/cup.14231 · 2022 · External reference
10.1158/1541-7786.mcr-12-0352
10.1158/1541-7786.mcr-12-0352 · External reference
10.1038/s41586-019-1012-y
10.1038/s41586-019-1012-y · External reference
10.1038/s41375-020-0944-4
10.1038/s41375-020-0944-4 · External reference
10.1158/1078-0432.ccr-13-1746
10.1158/1078-0432.ccr-13-1746 · External reference
Clinical and Therapeutic Implications of BRAF Fusions in Histiocytic Disorders
10.1038/s41408-022-00693-7 · 2022 · External reference
Disseminated Xanthogranuloma With BRAF Gene Fusion and Profound Response to MEK Inhibitor Therapy
10.1182/blood-2023-186973 · 2023 · External reference
Dabrafenib and Trametinib in Langerhans Cell Histiocytosis and Other Histiocytic Disorders
10.3324/haematol.2023.283295 · 2024 · External reference
10.1111/cup.14510
10.1111/cup.14510 · External reference
10.1097/pas.0000000000002394
10.1097/pas.0000000000002394 · External reference
Erdheim‐Chester Disease: A Rare Syndrome With a Characteristic Bone Scintigraphy Pattern
10.1007/s12149-007-0110-3 · 2008 · External reference
10.1111/j.1600-0560.2010.01650.x
10.1111/j.1600-0560.2010.01650.x · External reference
10.1182/blood-2012-05-430140
10.1182/blood-2012-05-430140 · External reference
10.1158/1535-7163.mct-18-1244
10.1158/1535-7163.mct-18-1244 · External reference
10.1101/gad.8.22.2770
10.1101/gad.8.22.2770 · External reference
10.1038/nature10630
10.1038/nature10630 · External reference
10.1038/nature10539
10.1038/nature10539 · External reference
10.1002/ijc.20865
10.1002/ijc.20865 · External reference
10.1038/s41598-020-74237-z
10.1038/s41598-020-74237-z · External reference
10.1016/j.prp.2018.05.001
10.1016/j.prp.2018.05.001 · External reference
